Chinese pharmaceutical company Innovent Biologics has signed an out-license agreement with Etana Biotechnologies to develop and commercialise cancer drug BYVASDA (Bevacizumab Biosimilar) in Indonesia.
19 Jan 2021
18 Jan 2021
Thermo Fisher Scientific announced the acquisition of Henogen, a Belgian viral vector manufacturing business belonging to Groupe Novasep, for about €725m ($875m) in cash.
07 Jan 2021
Fujifilm is set to invest about $2bn to build a new large-scale cell culture production site for biopharmaceuticals in the US.
25 Jun 2020
Symbiosis and AstraZeneca sign supply agreement for sterile manufacture of Covid-19 vaccine for clinical trials
Symbiosis Pharmaceutical Services, a specialist provider of pharmaceutical and vaccine development services, has announced it has signed a supply agreement with AstraZeneca for sterile manufacture of the Covid-19 recombinant adenovirus vaccine known as AZD1222 for AstraZeneca sponsored clinical trials.
12 Jun 2020
Novo Nordisk has agreed to acquire Corvidia Therapeutics, a portfolio company of life sciences venture capital firm Sofinnova Partners, in a deal valued at $2.1bn.
10 Sep 2018
BioCryst Pharmaceuticals has secured a $34.7m contract from the US Centers for Disease Control and Prevention (CDC) for the supply of up to 50,000 doses of its approved antiviral influenza therapy, RAPIVAB (peramivir injection) over a five-year period.
06 Sep 2018
Aurobindo Pharma USA has agreed to acquire selected portions of Sandoz US portfolio from Novartis for $900m of cash and $100m of potential earn-outs.
19 Jul 2018
UK-based EUSA Pharma has agreed to acquire the global rights of Sylvant (siltuximab), a rare blood disorder drug, from Janssen Sciences Ireland UC for $115m.
18 Jul 2018
Clinigen Group has acquired the global rights to Proleukin (aldesleukin, recombinant interleukin-2) outside the United States from Novartis.
11 Jul 2018
Takeda Pharmaceutical’s £45.3bn ($62bn) acquisition of Shire has been unconditionally approved by the US Federal Trade Commission (FTC).